-
-
-
Although Japanese encephalitis rarely occurs in travelers, certain groups and subsets of individuals have a risk of infection that can reach 1 in 5000 travelers per week. It is crucial to recognize those with increased risk, and to seriously consider immunizing them in order to prevent the potentially devastating sequelae of Japanese encephalitis.
-
Two recent publications cover common issues pertinent to travelers. There is a new way to expedite the diagnosis and treatment of myiasis, which is reviewed here. Included is also a synopsis of an illustrative article to make available to those who give advice to travelers regarding health care abroad.
-
Review of Efficacy of Ginkgo; Celebrex OK for Asthma Patients; Losartan Not Superior to Captopril; Alfa-Interferon Could Help Fight West Nile; FDA Actions
-
-
Careful evaluation of epidemiologic data from recent African outbreaks of meningococcal disease suggests that significant risks now extend beyond the sub-Saharan belt through the Rift Valley and Great Lakes regions into Mozambique, then into Namibia and Angola.
-
This invited article reviewing schistosomiasis in travelers describes the pertinent features of this disease as it presents in the nonimmune tourist.
-
-
Review of Efficacy of Ginkgo; Celebrex OK for Asthma Patients; Losartan Not Superior to Captopril; Alfa-Interferon Could Help Fight West Nile; FDA Actions
